News & Analysis on Clinical Trial Services & Contract Research And Development
update - WHO outlines biosimilarity requirements and inspection plan
The WHO has announced plans to extend its prequalification scheme to include cancer biosimilars and says it will pressure industry for fairer prices for all biologics.
Brineura's $702,000 (€640,000) a-year price tag reflects production costs and investment in tech used to administer the enzyme replacement therapy to the brain says BioMarin Pharmaceuticals.
There are several opportunities for contract research organizations (CROs) to advance patient centricity and many are looking to do so over the next three years, according to a report.
WIRB-Copernicus Group (WCG) has acquired the global patient recruitment, enrollment, and retention firm, ThreeWire.
The partnership helps accelerate site selection by enabling ACRP members to create a profile accessible to users of the DrugDev Spark Platform, the company’s unified clinical operations suite.
Pfizer says it is committed to addressing ongoing problems across Hospira's manufacturing network.
BPI Europe 2017
Vaxart says its tablet delivery platform has simplified vaccine production so significantly it may bring manufacturing currently contracted to Lonza back in-house.